Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 825
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Targeting the Hypoxic Response in Multiple Myeloma Cells Engrafted in the Bone Marrow

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody...

Will vitamin D improve the health of patients with heart failure?

We are trying to determine if supplemental vitamin D in heart failure patients will improve heart function...

How good are North American mosquitoes at spreading Zika virus?

Zika virus (ZIKV) is usually transmitted by Aedes mosquitoes. In different geographic locations...

Backer Badge Funded